Available to sourceHuman Prescription DrugGastrointestinal

Sodium Chloride

4 meq/mL · Injection Solution Concentrate

By Fresenius Kabi USA, LLC

NDC: 63323-099
Route: Intravenous
Therapeutic class: Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative
Marketing category: ANDA

Package sizes

10 VIAL, PLASTIC in 1 TRAY (63323-099-63) / 200 mL in 1 VIAL, PLASTIC (63323-099-03)NDC 63323-099-63Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.